Management dilemmas in prostate cancer

Hosp Pract (1995). 1996 Jan 15;31(1):79-86.

Abstract

Large numbers of men have an undetected prostate tumor, but in only a small proportion of cases do these lesions ever become clinically significant. That being so, it will take time to demonstrate the PSA screening or any given treatment strategy has benefit. Meanwhile, patients need help deciding whether to undergo screening and, if cancer is found whether to opt for aggressive treatment.

Publication types

  • Case Reports

MeSH terms

  • Biopsy, Needle
  • Combined Modality Therapy
  • Fatal Outcome
  • Gonadotropin-Releasing Hormone / therapeutic use
  • Humans
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Prostate-Specific Antigen / immunology
  • Prostatectomy
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / immunology
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / surgery
  • Time Factors

Substances

  • Gonadotropin-Releasing Hormone
  • Prostate-Specific Antigen